Read More 7 minute read Pharma Industry News Why Enveric Biosciences (NASDAQ: ENVB) may still be overlooked despite PTSD trial progress Enveric stock dips despite FDA and PTSD progress on EB-003. Find out why investors are cautious and what milestones could restore confidence. byVenkateshNovember 15, 2025